DXCM DexCom, Inc. Stock Quote

DXCM [NASD]

Healthcare | Diagnostics & Research | USA

Index	S&P 500	P/E	73.32	EPS (ttm)	4.99	Insider Own	0.70%	Shs Outstand	96.30M	Perf Week	-14.05%
Market Cap	38.65B	Forward P/E	107.98	EPS next Y	3.39	Insider Trans	-19.69%	Shs Float	95.78M	Perf Month	-1.89%
Income	493.60M	PEG	3.11	EPS next Q	0.46	Inst Own	98.00%	Short Float	3.80%	Perf Quarter	-6.57%
Sales	1.93B	P/S	20.06	EPS this Y	362.20%	Inst Trans	2.11%	Short Ratio	4.64	Perf Half Y	17.29%
Book/sh	19.76	P/B	18.52	EPS next Y	47.48%	ROA	12.80%	Target Price	466.00	Perf Year	0.46%
Cash/sh	24.93	P/C	14.68	EPS next 5Y	23.60%	ROE	31.20%	52W Range	305.63 - 456.23	Perf YTD	-1.02%
Dividend	-	P/FCF	163.77	EPS past 5Y	55.20%	ROI	15.80%	52W High	-19.79%	Beta	0.79
Dividend %	-	Quick Ratio	5.20	Sales past 5Y	36.80%	Gross Margin	67.70%	52W Low	19.73%	ATR	12.26
Employees	5500	Current Ratio	5.70	Sales Q/Q	24.70%	Oper. Margin	15.90%	RSI (14)	38.25	Volatility	3.47% 2.63%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	91.70%	Profit Margin	26.70%	Rel Volume	1.06	Prev Close	371.42
Shortable	Yes	LT Debt/Eq	0.92	Earnings	Apr 29 AMC	Payout	0.00%	Avg Volume	782.68K	Price	365.94
Recom	1.70	SMA20	-7.73%	SMA50	-3.22%	SMA200	-4.33%	Volume	832,894	Change	-1.48%

Apr-15-21

Initiated

Atlantic Equities

Overweight

$438

Jan-06-21

Upgrade

UBS

Neutral → Buy

$410 → $445

Oct-02-20

Downgrade

Wells Fargo

Equal Weight → Underweight

$420 → $350

May-27-20

Reiterated

Piper Sandler

Overweight

$375 → $450

May-14-20

Initiated

Wells Fargo

Equal Weight

$420

Mar-05-20

Initiated

Citigroup

Buy

$330

Nov-07-19

Upgrade

Guggenheim

Neutral → Buy

Nov-07-19

Reiterated

Canaccord Genuity

Buy

$185 → $195

Oct-23-19

Initiated

Stifel

Buy

Nov-28-18

Initiated

UBS

Neutral

$135

Oct-19-18

Upgrade

Goldman

Sell → Neutral

Sep-12-18

Upgrade

Northland Capital

Under Perform → Market Perform

Aug-02-18

Reiterated

Canaccord Genuity

Buy

$105 → $125

Jul-02-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-08-18

Upgrade

JP Morgan

Neutral → Overweight

May-11-18

Initiated

BofA/Merrill

Buy

$100

May-03-18

Reiterated

Canaccord Genuity

Buy

$81 → $85

Apr-04-18

Initiated

Guggenheim

Neutral

Apr-04-18

Initiated

Goldman

Sell

$57

Mar-23-18

Upgrade

Robert W. Baird

Neutral → Outperform

May-04-21 06:34PM	Was The Smart Money Right About DexCom (DXCM)? Insider Monkey
Apr-30-21 12:06PM	Why DexCom Stock Is Dropping Today Motley Fool -8.44%
10:24AM	DexCom (DXCM) Q1 Earnings and Revenues Surpass Estimates Zacks
09:21AM	DexCom Drops After Revenue Guidance Misses TheStreet.com
Apr-29-21 08:31PM	Dexcom Inc (DXCM) Q1 2021 Earnings Call Transcript Motley Fool
05:43PM	Dow Jones Futures: Amazon, Apple Suppliers, Tesla Rival Nio Among Earnings Movers After Whipsaw Market Rally Investor's Business Daily
05:15PM	DexCom (DXCM) Surpasses Q1 Earnings and Revenue Estimates Zacks
04:47PM	Medical Devices Giant Dexcom Tumbles Despite First-Quarter Beat And Raise Investor's Business Daily
04:02PM	Dexcom Reports First Quarter 2021 Financial Results Business Wire
02:30PM	DexCom, Inc. to Host Earnings Call ACCESSWIRE
Apr-28-21 09:13AM	Medical Products' Apr 29 Earnings Roster: TMO, BAX & More Zacks
Apr-27-21 09:02AM	Zacks.com featured highlights include: MercadoLibre, HealthEquity, DexCom, StoneCo and Las Vegas Sands Zacks
08:38AM	DexCom (DXCM) is in Overbought Territory: What's Next? Zacks
06:43AM	Can This Popular Reddit Stock Make You Rich? Motley Fool
Apr-26-21 08:53AM	5 Toxic Stocks That Could Break the Bank Zacks
Apr-23-21 08:45AM	DexCom (DXCM) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-22-21 12:33PM	Analysts Estimate DexCom (DXCM) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-21-21 07:12AM	3 Unstoppable Growth Stocks You Can Hold for Decades Motley Fool
Apr-20-21 09:00AM	Dexcom G6 CGM System Approved for Back of Upper Arm Wear, Offering Adults with Diabetes Greater Freedom CNW Group
Apr-18-21 05:12AM	What DexCom, Inc.'s (NASDAQ:DXCM) P/E Is Not Telling You Simply Wall St.
Apr-16-21 04:56PM	Manitoba and Saskatchewan Promise to Make Life-Changing Dexcom G6 CGM System Accessible for Children and Young Adults with Type 1 Diabetes CNW Group
Apr-07-21 03:00AM	Dexcom Starts Direct Distribution in the Netherlands Business Wire
Apr-01-21 04:15PM	Dexcom Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021 at 4:30 p.m. Eastern Time Business Wire
06:33AM	3 Overlooked Healthcare Stocks to Buy Right Now Motley Fool
Mar-25-21 01:05PM	Heres Why Carillon Tower Advisers Sold DexCom Inc. (DXCM) Insider Monkey
Mar-24-21 01:18PM	Is It Too Late to Buy DexCom (DXCM) Stock? Insider Monkey
Mar-23-21 01:18PM	Should You Invest in DexCom Inc. (DXCM)? Insider Monkey
10:12AM	Is DXCM Stock A Buy or Sell? Insider Monkey
08:30AM	Dexcom Promotes Jereme Sylvain to Chief Financial Officer Business Wire
Mar-22-21 07:14PM	Insulet Stock Rises as It Joins the Automated Insulin Device Competition Barrons.com
Mar-19-21 02:53AM	Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention? Simply Wall St.
Mar-18-21 12:02PM	Heres Why DexCom (DXCM) Fell to Artisan Mid Caps Bottom Contributors List Insider Monkey
Mar-10-21 08:00AM	How Much $10,000 Invested At The Financial Crisis Low Is Worth Now Investor's Business Daily
Mar-09-21 07:40AM	Zacks.com featured highlights include: DexCom, Casella Waste Systems, Ceridian HCM Holding and Hexcel Corp Zacks
Mar-08-21 08:54AM	Keep Your Portfolio Protected From These Toxic Stocks Zacks
Mar-03-21 11:23AM	Is DexCom (DXCM) A Good Stock To Buy? Insider Monkey -5.92%
Feb-19-21 11:51AM	Is DexCom (DXCM) Stock a Buy For 2021? Insider Monkey
Feb-18-21 06:06AM	4 Growth Stocks to Buy if the Stock Market Crashes Motley Fool
Feb-17-21 08:45AM	Dexcom Announces Upcoming Virtual Conference Presentations Business Wire
01:48AM	DexCom (NASDAQ:DXCM) Shareholders Have Enjoyed A Whopping 608% Share Price Gain Simply Wall St.
Feb-12-21 10:40AM	DexCom Gets a Quantitative Upgrade to Buy TheStreet.com
10:38AM	DexCom (DXCM) Q4 Earnings Match Estimates, Revenues Beat Zacks
Feb-11-21 10:31PM	Dexcom Inc (DXCM) Q4 2020 Earnings Call Transcript Motley Fool
05:25PM	DexCom (DXCM) Meets Q4 Earnings Estimates Zacks
04:46PM	Diabetes Stock Tumbles On Lackluster Sales Outlook, Mixed Earnings Investor's Business Daily
04:19PM	Recap: DexCom Q4 Earnings Benzinga
04:10PM	Dexcom Launches Inaugural Venture Capital Fund Business Wire
04:02PM	Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results Business Wire
02:30PM	DexCom, Inc. to Host Earnings Call ACCESSWIRE
Feb-10-21 10:38AM	Earnings Preview: DexCom Benzinga
09:12AM	Medical Products' Feb 11 Earnings Roster: DXCM, LH & More Zacks
Feb-09-21 06:30PM	Nick Jonas, Bruce Springsteen, Scissorhands And More: Which Super Bowl Commercial Drew The Most Interest? Benzinga
09:28AM	DexCom (DXCM) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-02-21 10:00AM	Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes Business Wire
Jan-19-21 08:30AM	Dexcom Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 11, 2021 at 4:30 p.m. Eastern Time Business Wire
06:08AM	Abbott vs Dexcom: Which Strong Buy Stock Could Deliver Higher Returns in 2021? TipRanks
Jan-18-21 01:55AM	Is DexCom (NASDAQ:DXCM) A Risky Investment? Simply Wall St.
Jan-13-21 09:32AM	DexCom (DXCM) Posts Solid Preliminary Q4 and 2020 Revenues Zacks
Jan-12-21 01:27PM	Teladoc (TDOC) and Dexcom Offer New Solutions for Diabetes Zacks
06:33AM	2 Healthcare Stocks That Crushed the Market Last Year -- And Still Have Room to Grow Motley Fool
Jan-11-21 12:46PM	DexCom 4th-Period Revenue Estimate Beats Analyst Expectations TheStreet.com
07:30AM	Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2020 and Provides Initial 2021 Outlook Business Wire
Jan-08-21 05:45PM	DexCom (DXCM) Gains But Lags Market: What You Should Know Zacks
Jan-07-21 01:18PM	12 Best Telemedicine Stocks to Buy Now Insider Monkey
Jan-05-21 08:30AM	Dexcom to Present at 39th Annual J.P. Morgan Healthcare Conference Business Wire
07:08AM	3 Recession-Proof Healthcare Stocks to Buy for 2021 Motley Fool
06:36AM	3 Nasdaq 100 Stocks That Can Make You a Boatload of Money in 2021 Motley Fool
Jan-03-21 08:19PM	14 Best Internet of Things Stocks To Buy Now Insider Monkey
Dec-30-20 06:06AM	4 High-Growth Trends You'll Want to Invest in for 2021 Motley Fool
Dec-24-20 05:45PM	DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
Dec-18-20 05:45PM	DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
Dec-17-20 07:10AM	Up 60% In 2020, Here's Why DexCom Is Just Getting Started Motley Fool
Dec-10-20 09:10AM	DexCom Shares Could Weaken Still Further in the Months Ahead TheStreet.com
Dec-09-20 06:12AM	DexCom Has a Lot to Prove in 2021 Motley Fool
Dec-08-20 06:08AM	Diabetes Awareness Month review: patients in Quebec and Canada have legitimate expectations CNW Group
Dec-07-20 10:23AM	Is DXCM A Good Stock To Buy Now? Insider Monkey
Dec-06-20 06:24AM	3 Top Healthcare Stocks to Buy Right Now Motley Fool
Dec-04-20 12:51AM	Returns On Capital - An Important Metric For DexCom (NASDAQ:DXCM) Simply Wall St.
Dec-01-20 02:40AM	Medtronic or Dexcom: Which Medical Device Stock Is Poised To Deliver Higher Gains? TipRanks
Nov-30-20 01:31PM	Zacks Industry Outlook Highlights: Teladoc, PRA Health and DexCom Zacks
Nov-28-20 06:50AM	3 Highest-Growth Stocks in the Market Today Motley Fool
Nov-27-20 09:07AM	IoMT Meets New Healthcare Needs: 3 MedTech Trends to Watch Zacks
Nov-25-20 10:40AM	DexCom Could Work Itself Lower in the Weeks Ahead TheStreet.com
Nov-19-20 07:04AM	Could DexCom Be a Millionaire-Maker Stock? Motley Fool
Nov-18-20 06:36AM	These 3 Medical Device Stocks Leave Biotech in the Dust Motley Fool
Nov-17-20 08:39AM	Better Buy: Abbott Laboratories vs. DexCom Motley Fool
Nov-14-20 09:08AM	Forget Snowflake! Buy This Ultra-High-Growth Stock Motley Fool
08:08AM	Forget Apple! Buy These 2 High-Growth Stocks Instead Motley Fool
Nov-12-20 08:45AM	Dexcom Announces Upcoming Virtual Conference Presentations Business Wire
06:53AM	5 Top Healthcare Stocks to Buy in November Motley Fool
Nov-10-20 10:00AM	Why DexCom Stock Crumbled in October Motley Fool
Nov-07-20 05:06AM	Why Is No One Talking About DexCom Stock? Motley Fool
Nov-04-20 04:39PM	Stock Upgrades: Dexcom Shows Rising Relative Strength Investor's Business Daily
Nov-03-20 10:18AM	Dexcom to Host Investor Day on December 9, 2020 Business Wire +6.34%
Oct-29-20 11:10AM	Go Slow on Any DexCom Purchases for Now TheStreet.com
08:10AM	DexCom, Inc. Just Recorded A 58% EPS Beat: Here's What Analysts Are Forecasting Next Simply Wall St.
Oct-28-20 10:30AM	DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates Zacks -8.28%
06:02AM	How DexCom Trounced Wall Street Estimates in Q3 Motley Fool
03:31AM	Dexcom Drops 9% As Revenue Beat Fails To Impress Investors SmarterAnalyst
Oct-27-20 09:01PM	Dexcom Inc (DXCM) Q3 2020 Earnings Call Transcript Motley Fool -8.94%

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAYER KEVIN R	Chairman, CEO & President	May 03	Sale	379.88	5,535	2,102,626	105,722	May 05 05:35 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Apr 26	Sale	415.83	500	207,915	19,241	Apr 27 06:27 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Apr 23	Sale	410.31	1,079	442,727	53,400	Apr 26 08:09 PM
Flynn Paul R	EVP, Global Revenue	Apr 15	Sale	400.00	758	303,200	12,306	Apr 16 04:44 PM
SAYER KEVIN R	Chairman, CEO & President	Apr 05	Sale	366.67	6,221	2,281,082	111,257	Apr 07 05:05 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Mar 26	Sale	350.00	500	175,000	19,741	Mar 30 05:45 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Mar 23	Sale	360.49	1,109	399,788	6,654	Mar 24 08:18 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Mar 23	Sale	360.49	1,079	388,967	54,479	Mar 24 08:18 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 11	Sale	355.86	1,867	664,391	16,136	Mar 12 05:41 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 10	Sale	362.92	2,700	979,876	18,003	Mar 12 05:41 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 10	Sale	362.92	5,566	2,019,996	55,558	Mar 12 05:40 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 10	Sale	362.92	14,044	5,096,806	117,478	Mar 12 05:40 PM
Leach Jacob Steven	EVP Chief Technology Officer	Mar 10	Sale	362.92	5,353	1,942,695	105,396	Mar 12 05:38 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Mar 10	Sale	362.92	3,471	1,259,685	20,241	Mar 12 05:39 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 10	Sale	362.22	6,509	2,357,688	45,165	Mar 12 05:38 PM
Abbey Donald	EVP Quality and Regulatory Aff	Mar 10	Sale	362.92	5,566	2,019,996	49,937	Mar 12 05:36 PM
Balo Andrew K	*	Mar 10	Sale	362.92	5,566	2,019,996	35,307	Mar 12 05:37 PM
Sylvain Jereme M	SVP, Finance & CAO	Mar 10	Sale	362.92	941	341,505	15,108	Mar 12 05:42 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 09	Sale	361.11	3,857	1,392,796	131,522	Mar 10 07:29 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 09	Sale	356.94	152	54,255	20,703	Mar 10 07:29 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Feb 26	Sale	396.79	500	198,395	18,078	Mar 02 07:31 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Feb 24	Sale	404.00	1,110	448,440	7,763	Feb 26 06:01 PM
Sylvain Jereme M	SVP, Finance & CAO	Feb 24	Sale	404.00	600	242,400	10,700	Feb 26 06:02 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Feb 23	Sale	406.98	1,079	439,131	55,823	Feb 24 07:57 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Feb 19	Sale	420.01	1,800	756,025	56,902	Feb 23 06:33 PM
AUGUSTINOS NICHOLAS	Director	Feb 16	Sale	412.03	1,875	772,556	10,092	Feb 17 09:36 PM
SAYER KEVIN R	Chairman, CEO & President	Feb 01	Sale	378.17	12,468	4,714,965	131,934	Feb 03 07:34 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jan 27	Sale	359.70	500	179,850	18,578	Jan 29 05:08 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jan 22	Sale	368.84	1,110	409,407	8,873	Jan 25 08:21 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jan 22	Sale	368.82	1,079	397,960	58,702	Jan 25 08:21 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 13	Sale	353.55	7,073	2,500,653	144,402	Jan 14 05:06 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 12	Sale	362.09	39,949	14,465,252	151,475	Jan 14 05:06 PM
AUGUSTINOS NICHOLAS	Director	Jan 06	Sale	375.00	625	234,375	11,967	Jan 07 04:40 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jan 04	Sale	366.06	11,025	4,035,812	21,524	Jan 06 05:10 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Dec 28	Sale	355.39	500	177,695	19,078	Dec 29 08:58 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Dec 23	Sale	359.92	1,110	399,516	9,983	Dec 28 05:43 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Dec 23	Sale	359.85	1,079	388,276	59,781	Dec 28 05:43 PM
AUGUSTINOS NICHOLAS	Director	Dec 16	Sale	354.55	1,250	443,182	12,592	Dec 18 07:53 PM
Heller Bridgette P	Director	Dec 15	Sale	356.65	375	133,744	3,448	Dec 17 05:12 PM
SAYER KEVIN R	Chairman, CEO & President	Dec 01	Sale	322.18	13,233	4,263,358	115,514	Dec 03 05:11 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Dec 01	Sale	325.00	6,154	2,000,050	19,578	Dec 03 05:11 PM
Sylvain Jereme M	SVP, Finance & CAO	Nov 24	Sale	320.37	600	192,222	11,300	Nov 25 04:50 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Nov 23	Sale	318.99	1,079	344,190	60,860	Nov 25 04:50 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Nov 23	Sale	318.99	1,110	354,079	11,093	Nov 25 04:50 PM
FOLETTA MARK G	Director	Nov 16	Sale	341.32	1,000	341,320	13,202	Nov 18 06:57 PM
Sylvain Jereme M	SVP, Finance & CAO	Nov 10	Sale	336.22	632	212,491	11,900	Nov 12 05:39 PM
SAYER KEVIN R	President, CEO and Chairman	Oct 29	Sale	340.14	13,830	4,704,197	128,747	Oct 30 05:01 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Oct 23	Sale	403.18	1,079	435,030	61,939	Oct 27 06:20 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Oct 23	Sale	403.10	1,110	447,444	12,203	Oct 27 06:19 PM
FOLETTA MARK G	Director	Oct 15	Sale	396.82	1,000	396,819	14,202	Oct 19 04:30 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Oct 01	Sale	420.00	200	84,000	63,018	Oct 02 06:08 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 30	Sale	410.32	2,000	820,637	63,218	Oct 02 06:08 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 25	Sale	400.07	2,000	800,137	65,218	Sep 28 05:35 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Sep 24	Sale	380.95	1,530	582,861	0	Sep 28 05:35 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 23	Sale	395.11	1,079	426,324	67,218	Sep 24 04:30 PM
AUGUSTINOS NICHOLAS	Director	Sep 16	Sale	399.78	1,875	749,596	13,842	Sep 18 04:57 PM
ALTMAN STEVEN R	Director	Sep 15	Sale	393.92	30,000	11,817,600	12,980	Sep 16 07:36 PM
Balo Andrew K	*	Sep 15	Sale	397.35	5,256	2,088,490	35,567	Sep 16 04:44 PM
FOLETTA MARK G	Director	Sep 14	Sale	394.14	1,000	394,136	15,202	Sep 16 04:44 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Sep 10	Sale	400.59	12,193	4,884,343	44,124	Sep 11 06:57 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Sep 10	Sale	400.62	2,102	842,104	17,753	Sep 11 06:59 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Sep 09	Sale	398.30	2,444	973,450	25,732	Sep 11 06:58 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 09	Sale	398.30	4,580	1,824,223	68,297	Sep 11 06:58 PM
SAYER KEVIN R	President, CEO and Chairman	Sep 09	Sale	398.30	9,965	3,969,079	142,577	Sep 11 06:59 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Sep 09	Sale	398.30	2,226	886,620	19,855	Sep 11 06:59 PM
Sylvain Jereme M	SVP, Finance & CAO	Sep 09	Sale	398.30	289	115,109	12,532	Sep 11 06:59 PM
Balo Andrew K	*	Sep 09	Sale	398.30	4,580	1,824,223	40,823	Sep 11 06:57 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Sep 09	Sale	398.30	12,886	5,132,520	56,317	Sep 11 06:57 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Sep 09	Sale	398.30	4,699	1,871,621	46,812	Sep 11 06:58 PM
Leach Jacob Steven	EVP Chief Technology Officer	Sep 09	Sale	398.30	3,860	1,537,446	103,548	Sep 11 06:58 PM
Abbey Donald	EVP Quality and Regulatory Aff	Sep 09	Sale	394.43	9,739	3,841,392	50,202	Sep 11 06:57 PM
Sylvain Jereme M	SVP, Finance & CAO	Aug 24	Sale	427.41	600	256,446	12,817	Aug 26 07:04 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Aug 24	Sale	427.22	1,530	653,642	1,530	Aug 26 07:03 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Aug 24	Sale	427.24	1,531	654,107	72,877	Aug 26 07:04 PM
Abbey Donald	EVP Quality and Regulatory Aff	Aug 24	Sale	424.66	9,766	4,147,227	59,941	Aug 26 07:03 PM
ALTMAN STEVEN R	Director	Aug 10	Sale	435.05	2,000	870,093	42,980	Aug 12 05:11 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Aug 10	Sale	439.31	500	219,655	28,176	Aug 12 05:11 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Aug 10	Sale	439.31	400	175,724	22,041	Aug 12 05:11 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jul 23	Sale	427.31	1,531	654,213	74,408	Jul 27 05:53 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jul 23	Sale	427.29	1,531	654,188	3,060	Jul 27 05:53 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Jul 10	Sale	439.33	400	175,732	22,441	Jul 14 04:27 PM
ALTMAN STEVEN R	Director	Jul 10	Sale	437.50	2,000	874,993	44,980	Jul 14 04:27 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jul 09	Sale	435.80	500	217,900	28,676	Jul 10 05:13 PM
SAYER KEVIN R	President, CEO and Chairman	Jul 06	Sale	420.94	6,000	2,525,662	152,542	Jul 08 07:01 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jun 23	Sale	409.41	1,531	626,807	4,591	Jun 25 06:45 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jun 23	Sale	409.37	1,531	626,750	75,939	Jun 25 06:45 PM
AUGUSTINOS NICHOLAS	Director	Jun 15	Sale	366.65	1,875	687,462	15,717	Jun 17 06:01 PM
Balo Andrew K	*	Jun 15	Sale	366.47	6,522	2,390,096	45,376	Jun 17 06:01 PM
Leach Jacob Steven	EVP Chief Technology Officer	Jun 11	Sale	376.76	19,129	7,207,029	107,369	Jun 15 06:00 PM
ALTMAN STEVEN R	Director	Jun 10	Sale	385.71	2,000	771,413	46,980	Jun 12 06:54 PM
KAHN BARBARA	Director	Jun 10	Sale	380.71	7,000	2,665,001	6,879	Jun 12 06:54 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Jun 10	Sale	385.22	400	154,088	22,841	Jun 12 06:54 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jun 09	Sale	375.36	500	187,680	29,176	Jun 10 05:50 PM
SAYER KEVIN R	President, CEO and Chairman	Jun 01	Sale	376.57	6,000	2,259,400	158,542	Jun 02 04:43 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	May 26	Sale	408.49	1,474	602,114	23,241	May 28 06:47 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	May 22	Sale	396.74	1,531	607,409	77,470	May 27 06:06 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	May 22	Sale	396.74	1,531	607,409	6,122	May 27 05:56 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	May 11	Sale	404.05	400	161,620	24,715	May 13 06:30 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	May 11	Sale	404.05	500	202,025	29,676	May 13 06:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience